Shah, Urvi A.

GPRC5D-Targeted CAR T Cells for Myeloma

Mailankody, S., Devlin, S. M., Landa, J., Nath, K., Diamonte, C., Carstens, E. J., Russo, D., Auclair, R., Fitzgerald, L., Cadzin, B., et al. (2022) · New England Journal of Medicine

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 411

Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Mailankody, S., Diamonte, C., Fitzgerald, L., Kane, P., Wang, X., Sikder, D. S., Senechal, B., Bermudez, V. P., Frias, D., Morgan, J., et al. (2021) · Blood

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 30

Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population

Joseph, J. M., Hillengass, J., Tang, L., Lesokhin, A. M., Landgren, O., Usmani, S. Z., Moysich, K. B., McCann, S. E., & Shah, U. A. (2023) · Blood Advances

Multiple Myeloma Research and TreatmentsNutritional Studies and Diet

Cited by 17

Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001

Maura, F., Diamond, B., Maclachlan, K. H., Derkach, A., Yellapantula, V. D., Rustad, E. H., Hultcrantz, M., Shah, U. A., Hong, J., Landau, H. J., et al. (2021) · Clinical Cancer Research

Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics

Cited by 10